1-9 of 9
Wim L. J. van Putten
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Complete Sequencing of TP53 Predicts Poor Response to Systemic Therapy of Advanced Breast Cancer

Els M. J. J. Berns, John A. Foekens, Rolf Vossen, Maxime P. Look, Peter Devilee, Sonja C. Henzen-Logmans, Iris L. van Staveren, Wim L. J. van Putten, Mats Inganäs, Marion E. Meijer-van Gelder, Cees Cornelisse, Cassandra J. C. Claassen, Henk Portengen, Bert Bakker, Jan G. M. Klijn
Journal: Cancer Research
Cancer Res (2000) 60 (8): 2155–2162.
Published: 01 April 2000
View article titled, Complete Sequencing of <em>TP53 </em>Predicts Poor Response to Systemic Therapy of Advanced Breast Cancer
Open the PDF for Complete Sequencing of <em>TP53 </em>Predicts Poor Response to Systemic Therapy of Advanced Breast Cancer in another window
Journal Articles

The Urokinase System of Plasminogen Activation and Prognosis in 2780 Breast Cancer Patients

John A. Foekens, Harry A. Peters, Maxime P. Look, Henk Portengen, Manfred Schmitt, Michael D. Kramer, Nils Brünner, Fritz Jänicke, Marion E. Meijer-van Gelder, Sonja C. Henzen-Logmans, Wim L. J. van Putten, Jan G. M. Klijn
Journal: Cancer Research
Cancer Res (2000) 60 (3): 636–643.
Published: 01 February 2000
View article titled, The Urokinase System of Plasminogen Activation and Prognosis in 2780 Breast Cancer Patients
Open the PDF for The Urokinase System of Plasminogen Activation and Prognosis in 2780 Breast Cancer Patients in another window
Journal Articles

Plasminogen Activator Inhibitor-2: Prognostic Relevance in 1012 Patients with Primary Breast Cancer

John A. Foekens, Frank Buessecker, Harry A. Peters, Ute Krainick, Wim L. J. van Putten, Maxime P. Look, Jan G.M. Klijn, Michael D. Kramer
Journal: Cancer Research
Cancer Res (1995) 55 (7): 1423–1427.
Published: 01 April 1995
View article titled, Plasminogen Activator Inhibitor-2: Prognostic Relevance in 1012 Patients with Primary Breast Cancer
Open the PDF for Plasminogen Activator Inhibitor-2: Prognostic Relevance in 1012 Patients with Primary Breast Cancer in another window
Journal Articles

Prognostic Value of Urokinase-type Plasminogen Activator in 671 Primary Breast Cancer Patients

John A. Foekens, Manfred Schmitt, Wim L. J. van Putten, Harry A. Peters, Marijke Bontenbal, Fritz Jänicke, Jan G. M. Klijn
Journal: Cancer Research
Cancer Res (1992) 52 (21): 6101–6105.
Published: 01 November 1992
View article titled, Prognostic Value of Urokinase-type Plasminogen Activator in 671 Primary Breast Cancer Patients
Open the PDF for Prognostic Value of Urokinase-type Plasminogen Activator in 671 Primary Breast Cancer Patients in another window
Journal Articles

c-myc Amplification Is a Better Prognostic Factor than HER2/neu Amplification in Primary Breast Cancer

Els M. J. J. Berns, Jan G. M. Klijn, Wim L. J. van Putten, Iris L. van Staveren, Henk Portengen, John A. Foekens
Journal: Cancer Research
Cancer Res (1992) 52 (5): 1107–1113.
Published: 01 March 1992
View article titled, c-<em>myc</em> Amplification Is a Better Prognostic Factor than <em>HER2/neu</em> Amplification in Primary Breast Cancer
Open the PDF for c-<em>myc</em> Amplification Is a Better Prognostic Factor than <em>HER2/neu</em> Amplification in Primary Breast Cancer in another window
Journal Articles

Exogenous Interleukin 2 Recruits in Vitro Lymphokine-activated Killer Activity by in Vivo Activated Lymphocytes

Cor H. J. Lamers, Jan Willem Gratama, Wim L. J. van Putten, Gerrit Stoter, Reinder L. H. Bolhuis
Journal: Cancer Research
Cancer Res (1991) 51 (9): 2324–2328.
Published: 01 May 1991
View article titled, Exogenous Interleukin 2 Recruits <em>in Vitro</em> Lymphokine-activated Killer Activity by <em>in Vivo</em> Activated Lymphocytes
Open the PDF for Exogenous Interleukin 2 Recruits <em>in Vitro</em> Lymphokine-activated Killer Activity by <em>in Vivo</em> Activated Lymphocytes in another window
Journal Articles

Prediction of Relapse and Survival in Breast Cancer Patients by pS2 Protein Status

John A. Foekens, Marie-Christine Rio, Patrick Seguin, Wim L. J. van Putten, Joël Fauque, Marius Nap, Jan G. M. Klijn, Pierre Chambon
Journal: Cancer Research
Cancer Res (1990) 50 (13): 3832–3837.
Published: 01 July 1990
View article titled, Prediction of Relapse and Survival in Breast Cancer Patients by pS2 Protein Status
Open the PDF for Prediction of Relapse and Survival in Breast Cancer Patients by pS2 Protein Status in another window
Journal Articles

Prognostic Value of Receptors for Insulin-like Growth Factor 1, Somatostatin, and Epidermal Growth Factor in Human Breast Cancer

John A. Foekens, Henk Portengen, Wim L. J. van Putten, Anita M. A. C. Trapman, Jean-Claude Reubi, Jana Alexieva-Figusch, Jan G. M. Klijn
Journal: Cancer Research
Cancer Res (1989) 49 (24_Part_1): 7002–7009.
Published: 15 December 1989
View article titled, Prognostic Value of Receptors for Insulin-like Growth Factor 1, Somatostatin, and Epidermal Growth Factor in Human Breast Cancer
Open the PDF for Prognostic Value of Receptors for Insulin-like Growth Factor 1, Somatostatin, and Epidermal Growth Factor in Human Breast Cancer in another window
Journal Articles

Prognostic Value of Estrogen and Progesterone Receptors Measured by Enzyme Immunoassays in Human Breast Tumor Cytosols

John A. Foekens, Henk Portengen, Wim L. J. van Putten, Harry A. Peters, Hendrik L. J. M. Krijnen, Jana Alexieva-Figusch, Jan G. M. Klijn
Journal: Cancer Research
Cancer Res (1989) 49 (21): 5823–5828.
Published: 01 November 1989
View article titled, Prognostic Value of Estrogen and Progesterone Receptors Measured by Enzyme Immunoassays in Human Breast Tumor Cytosols
Open the PDF for Prognostic Value of Estrogen and Progesterone Receptors Measured by Enzyme Immunoassays in Human Breast Tumor Cytosols in another window